TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and Webcast

Company to Provide Corporate and Clinical Overview on Thursday, April 5, 2018, 4:30pm ET

[/vc_column_text][vc_column_text]JACKSONVILLE, FLORIDA – March 29, 2017 – TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that the Company will host a conference call and live audio webcast on Thursday, April 5, 2018, at 4:30 p.m. ET, to provide a corporate and clinical update for the fourth quarter and year end 2017.

Reserve Your Seat: Register Today

The event will be webcast live via the Internet on:

April 5, 2018

4:30 PM ET

Click here to register today, or visit https://www.markertherapeutics.com/register/.

Day-of Call-in Information:

To access the live conference call on April 5, 2018, at 4:30pm ET you may use:

  • (855) 238-2333 (U.S.)
  • (412) 317-5215 (International)

To access the live audio webcast, visit the Events section of the TapImmune website: https://www.markertherapeutics.com/events. The webcast will also be archived for 90 days beginning at approximately 6:30 p.m. ET, on April 5, 2018.[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer]